Accordingly, DNase1-mediated reversal of microglia activation, cerebrovascular protection and anti-hemorrhagic effects after ischemic stroke were abolished by co-administration of the cGAS product cGAMP, whereas cGAS deficiency rescued t-PA-associated BBB disruption and cerebral hemorrhage [397]. The gene discussed is DNASE1; the disease is ischemic stroke.